Us Bancorp \De\ Lannett CO Inc Transaction History

Us Bancorp \De\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$5.75 - $7.13 $2,466 - $3,058	-429 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$4.9 - $7.12 $2,102 - $3,054	429 New	429 $3,000
Q4 2019 Feb 04, 2020	SELL	$8.49 - $12.81 $781 - $1,178	-92 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$5.58 - $14.47 $513 - $1,331	92 New	92 $1,000
Q3 2018 Nov 01, 2018	SELL	$4.75 - $14.5 $437 - $1,334	-92 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$13.3 - $17.45 $718 - $942	54 Added 142.11%	92 $1,000
Q3 2017 Nov 13, 2017	BUY	$15.1 - $19.25 $573 - $731	38	38 $1,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.